
New medication for pancreatic drug patients approved by the FDA
According to a Fox 2 Detroit report, Lynparza, a new drug, has been granted approval in the U.S. for treatment of pancreatic cancer patients whose ailments have not been advanced on 16 weeks of a first-line platinum-based chemotherapy regimen. Lynparza…